Christopher Melani

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Michail S. Lionakis, Kieron Dunleavy, Mark Roschewski et al. · Cancer Cell · 2017 · 484 citations · Full text

Lymphoid Neoplasia, Malignant Blood Disorder, Primary Cns Lymphoma +5

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

Kieron Dunleavy, Michelle A. Fanale, Jeremy S. Abramson et al. · The Lancet Haematology · 2018 · 226 citations

Hematological Malignancy, Lymphoid Neoplasia, Single-arm Phase 2 +9

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Mark Roschewski, Kieron Dunleavy, Jeremy S. Abramson et al. · Journal of Clinical Oncology · 2020 · 146 citations · Full text

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

Christopher Melani, Ranjana H. Advani, Mark Roschewski et al. · Haematologica · 2018 · 87 citations · Full text

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

Christopher Melani, Rahul Lakhotia, Stefania Pittaluga et al. · New England Journal of Medicine · 2024 · 58 citations · Full text